Using IVR to Maintain ACS Patients on Best Practice Guidelines

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 654 participants.

Also called NCT01260207

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 654 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01260207
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01260207. Randomized; single masking; primary purpose treatment. Start 2010-01 (actual); primary completion 2014-12-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Using IVR to Maintain ACS Patients on Best Practice Guidelines
Acronym
IVR-ACS BPG
Condition
Acute Coronary Syndrome
Condition
Medication Adherence
Intervention (Other)
IVR group
Lead sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (class: other)
Collaborator
Ottawa Heart Institute Research Corporation (class: other)

Record details

Record id
cardio:ct-nct01260207
Content hash
8f1605a4836395363af3f96f57ad096e6a52e66af9065de0596e5b6e345e0acf